Concepedia

Dongcheng Dai

DD

Statistics

Publications

22

Citations

1.3K

H-Index

19

Active since

1983

Affiliations

Siga Technologies (United States)(Current)

Shanghai Institute of Materia Medica

Chinese Academy of Sciences

Amgen (United States)

Scripps Research Institute

Dongcheng Dai is an author at Siga Technologies (United States) specializing in medicinal chemistry, virology, and drug discovery.

ORCID

Publications per year

1983–2025

22

Publications

22

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach et al. · Antimicrobial Agents and Chemotherapy · 2012 · 164 citations · Full text

, , +17

Identification of a Broad-Spectrum Arenavirus Entry Inhibitor

Ryan A. Larson, Dongcheng Dai, Virginia T. Hosack et al. · Journal of Virology · 2008 · 143 citations · Full text

, , +17

Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu et al. · Antimicrobial Agents and Chemotherapy · 2013 · 112 citations · Full text

, , +17

pH-Induced Activation of Arenavirus Membrane Fusion Is Antagonized by Small-Molecule Inhibitors

Joanne York, Dongcheng Dai, Sean M. Amberg et al. · Journal of Virology · 2008 · 104 citations · Full text

, , +17

Evaluation of Lassa antiviral compound ST-193 in a guinea pig model

Kathleen A. Cashman, Mark Smith, Nancy Twenhafel et al. · Antiviral Research · 2011 · 97 citations · Full text

, , +11

1–5 of 22